Sign inJoin waitlistJoin the waitlist

RD

Ronald Dubowy

Pediatrics / Pediatric Hematology-Oncology

Credentials: · ·

History

Medical Doctor with an active medical license in the state of New York that expires in 2027.
2024–2027
Stanford University School of Medicine

Research

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis
Journal of Clinical Oncology · 2017 · 330 citations
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation…
The Lancet Oncology · 2022 · 223 citations
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
Blood · 2015 · 206 citations

AS
Abdul Souid
8 papers
Holcombe Grier
4 papers
PS
Peter Sadowitz
4 papers
Susan Blaney
4 papers
AZ
Andrew Zelenetz
3 papers
AL
Anne Marie Langevin
3 papers
FK
Faith Kung
3 papers
Richard Furman
3 papers
Steven Coutre
3 papers
SO
Susan O'Brien
3 papers
YR
Yaddanapudi Ravindranath
3 papers
CH
Craig Hurwitz
2 papers